Mohammad-Beigi Hossein, Shojaosadati Seyed Abbas, Morshedi Dina, Mirzazadeh Negar, Arpanaei Ayyoob
Biotechnology Group, Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, Iran.
Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Iran J Biotechnol. 2016 Mar;14(1):45-50. doi: 10.15171/ijb.1168.
Recently, applications of albumin nanoparticles as drug delivery carriers have increased. Most toxicology studies have shown that surface chemistry and size of nanoparticles play an important role in biocompatibility and toxicity.
The effect of desolvating agents with different chemical properties on the size of synthesized HSA NPs was investigated.
Acetone, ethanol, methanol, and acetonitrile were used to synthesize HSA NPs with controllable size by desolvation method. Scanning electron microscopy (SEM), dynamic light scattering (DLS), and circular dichroism (CD) were employed to characterize produced particles. Finally, the toxicity of HSA NPs synthesized under different conditions was evaluated on PC-12 cells.
The sizes of synthesized particles differed according to the different solvents used. The sizes were 275.3 nm, 155.3 nm, 100.11 nm, and 66.2 nm for acetonitrile, ethanol, acetone, and methanol, respectively. CD showed that larger NPs had more changes in the secondary structures. Finally, the toxicity monitored on the cultured PC-12 cells showed no significant toxic effect through treating with these NPs at different concentrations (0-500 μg.mL).
The size of HSA NPs has a strong dependency on the desolvating agent. The mechanism in which the desolvating agent affects the size of HSA NPs is complex. Various factors such as dielectric constant, polarity, functional groups, and hydrogen bonding of the solvents have the potential to affect the size and structure of HSA NPs. CD analysis suggested that the solvent denaturing capability had a critical effect on the HSA particle size. The stronger denaturing capability of the solvent resulted in the larger HSA particle size.
近年来,白蛋白纳米颗粒作为药物递送载体的应用有所增加。大多数毒理学研究表明,纳米颗粒的表面化学性质和尺寸在生物相容性和毒性方面起着重要作用。
研究具有不同化学性质的去溶剂化剂对合成的人血清白蛋白纳米颗粒(HSA NPs)尺寸的影响。
使用丙酮、乙醇、甲醇和乙腈通过去溶剂化法合成尺寸可控的HSA NPs。采用扫描电子显微镜(SEM)、动态光散射(DLS)和圆二色性(CD)对制备的颗粒进行表征。最后,评估在不同条件下合成的HSA NPs对PC-12细胞的毒性。
根据所使用的不同溶剂,合成颗粒的尺寸有所不同。乙腈、乙醇、丙酮和甲醇合成的颗粒尺寸分别为275.3 nm、155.3 nm、100.11 nm和66.2 nm。CD显示较大的纳米颗粒二级结构变化更大。最后,对培养的PC-12细胞进行毒性监测,结果表明在不同浓度(0 - 500 μg/mL)下用这些纳米颗粒处理未显示出明显的毒性作用。
HSA NPs的尺寸强烈依赖于去溶剂化剂。去溶剂化剂影响HSA NPs尺寸的机制很复杂。溶剂的介电常数、极性、官能团和氢键等各种因素都有可能影响HSA NPs的尺寸和结构。CD分析表明溶剂的变性能力对HSA颗粒尺寸有关键影响。溶剂的变性能力越强,HSA颗粒尺寸越大。